MedPath

EVERIMMUNE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

phase_1_2
1 (50.0%)
Phase 2
1 (50.0%)

A Study of Oncobax®-AK in Patients With Advanced Solid Tumors

Phase 2
Recruiting
Conditions
Carcinoma, Renal Cell
Carcinoma, Non-Small-Cell Lung
First Posted Date
2023-05-19
Last Posted Date
2023-05-19
Lead Sponsor
EverImmune
Target Recruit Count
122
Registration Number
NCT05865730
Locations
🇧🇪

CHU Ambroise Paré, Mons, Belgium

🇫🇷

Centre Georges Francois Leclerc, Dijon, France

🇫🇷

Institut Gustave Roussy, Paris, France

and more 1 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath